These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 1330621

  • 1. Methohexitone antagonises kainate and epileptiform activity in rat neocortical slices.
    Palmer AJ, Zeman S, Lodge D.
    Eur J Pharmacol; 1992 Oct 20; 221(2-3):205-9. PubMed ID: 1330621
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
    Zeman S, Lodge D.
    Br J Pharmacol; 1992 Jun 20; 106(2):367-72. PubMed ID: 1382781
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro.
    Pook P, Brugger F, Hawkins NS, Clark KC, Watkins JC, Evans RH.
    Br J Pharmacol; 1993 Jan 20; 108(1):179-84. PubMed ID: 8094024
    [Abstract] [Full Text] [Related]

  • 4. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC, Guet T, Cordi A, Lepagnol JM.
    Eur J Pharmacol; 1992 May 14; 215(2-3):237-44. PubMed ID: 1382998
    [Abstract] [Full Text] [Related]

  • 5. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro.
    Fletcher EJ, Martin D, Aram JA, Lodge D, Honoré T.
    Br J Pharmacol; 1988 Oct 14; 95(2):585-97. PubMed ID: 2906560
    [Abstract] [Full Text] [Related]

  • 6. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC, Guet T, Bobichon C, Moreau C, Curutchet P, Lambolez B, de Carvalho LP, Cordi A, Lepagnol JM.
    Mol Pharmacol; 1992 Feb 14; 41(2):337-45. PubMed ID: 1371583
    [Abstract] [Full Text] [Related]

  • 7. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
    Wilding TJ, Huettner JE.
    Mol Pharmacol; 1996 Mar 14; 49(3):540-6. PubMed ID: 8643094
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ, Leong W.
    Brain Res; 1993 Nov 19; 628(1-2):1-7. PubMed ID: 7508807
    [Abstract] [Full Text] [Related]

  • 9. Physiological unmasking of new glutamatergic pathways in the dentate gyrus of hippocampal slices from kainate-induced epileptic rats.
    Patrylo PR, Dudek FE.
    J Neurophysiol; 1998 Jan 19; 79(1):418-29. PubMed ID: 9425210
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenate.
    Stone TW.
    Br J Pharmacol; 1990 Dec 19; 101(4):847-52. PubMed ID: 1964821
    [Abstract] [Full Text] [Related]

  • 11. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones.
    Dinse A, Föhr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU.
    Br J Anaesth; 2005 Apr 19; 94(4):479-85. PubMed ID: 15695547
    [Abstract] [Full Text] [Related]

  • 12. The effects of copper ions on glutamate receptors in cultured rat cortical neurons.
    Weiser T, Wienrich M.
    Brain Res; 1996 Dec 02; 742(1-2):211-8. PubMed ID: 9117397
    [Abstract] [Full Text] [Related]

  • 13. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
    Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T.
    Science; 1990 Feb 02; 247(4942):571-4. PubMed ID: 2154034
    [Abstract] [Full Text] [Related]

  • 14. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
    Kristensen BW, Noraberg J, Jakobsen B, Gramsbergen JB, Ebert B, Zimmer J.
    Brain Res; 1999 Sep 11; 841(1-2):143-59. PubMed ID: 10546997
    [Abstract] [Full Text] [Related]

  • 15. Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices.
    von Kügelgen I, Späth L, Starke K.
    Br J Pharmacol; 1993 Dec 11; 110(4):1544-50. PubMed ID: 7508327
    [Abstract] [Full Text] [Related]

  • 16. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K.
    J Pharmacol Exp Ther; 1996 Jan 11; 276(1):84-92. PubMed ID: 8558460
    [Abstract] [Full Text] [Related]

  • 17. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E, Cox JA, Seeburg PH, Verdoorn TA.
    Mol Pharmacol; 1992 Nov 11; 42(5):864-71. PubMed ID: 1279377
    [Abstract] [Full Text] [Related]

  • 18. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S, Cebers G, Kalda A.
    Biochem Pharmacol; 1995 Nov 27; 50(11):1761-74. PubMed ID: 8615854
    [Abstract] [Full Text] [Related]

  • 19. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    Verdoorn TA, Kleckner NW, Dingledine R.
    Mol Pharmacol; 1989 Mar 27; 35(3):360-8. PubMed ID: 2564633
    [Abstract] [Full Text] [Related]

  • 20. Two types of network oscillations in neocortex mediated by distinct glutamate receptor subtypes and neuronal populations.
    Flint AC, Connors BW.
    J Neurophysiol; 1996 Feb 27; 75(2):951-7. PubMed ID: 8714667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.